Literature DB >> 33708149

Elevated Brain Glutamate Levels in Bipolar Disorder and Pyruvate Carboxylase-Mediated Anaplerosis.

Jun Shen1, Jyoti Singh Tomar1.   

Abstract

In vivo 1H magnetic resonance spectroscopy studies have found elevated brain glutamate or glutamate + glutamine levels in bipolar disorder with surprisingly high reproducibility. We propose that the elevated glutamate levels in bipolar disorder can be explained by increased pyruvate carboxylase-mediated anaplerosis in brain. Multiple independent lines of evidence supporting increased pyruvate carboxylase-mediated anaplerosis as a common mechanism underlying glutamatergic hyperactivity in bipolar disorder and the positive association between bipolar disorder and obesity are also described.
Copyright © 2021 Shen and Tomar.

Entities:  

Keywords:  bipolar disorder; glutamate; magnetic resonance spectroscopy; obesity; pyruvate carboxylase

Year:  2021        PMID: 33708149      PMCID: PMC7940766          DOI: 10.3389/fpsyt.2021.640977

Source DB:  PubMed          Journal:  Front Psychiatry        ISSN: 1664-0640            Impact factor:   4.157


  91 in total

Review 1.  Strategies for metabolic exchange between glial cells and neurons.

Authors:  J W Deitmer
Journal:  Respir Physiol       Date:  2001-12

2.  Immunostaining of carbamoylphosphate synthase II and fatty acid synthase in glial cells in rat, mouse, and hamster brains suggests roles for carbonic anhydrase in biosynthetic processes.

Authors:  W Cammer
Journal:  Neurosci Lett       Date:  1991-08-19       Impact factor: 3.046

3.  Zonisamide for weight reduction in obese adults: a 1-year randomized controlled trial.

Authors:  Kishore M Gadde; Mariko F Kopping; H Ryan Wagner; Gretchen M Yonish; David B Allison; George A Bray
Journal:  Arch Intern Med       Date:  2012-11-12

Review 4.  Mitochondrial dysfunction in bipolar disorder.

Authors:  T Kato; N Kato
Journal:  Bipolar Disord       Date:  2000-09       Impact factor: 6.744

5.  13C magnetic resonance spectroscopy studies of alterations in glutamate neurotransmission.

Authors:  Jun Shen
Journal:  Biol Psychiatry       Date:  2005-09-30       Impact factor: 13.382

6.  The burden of obesity among adults with bipolar disorder in the United States.

Authors:  Benjamin I Goldstein; Shang-Min Liu; Nevena Zivkovic; Ayal Schaffer; Lung-Chang Chien; Carlos Blanco
Journal:  Bipolar Disord       Date:  2011-06       Impact factor: 6.744

7.  Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue.

Authors:  Iris C Maurer; Patricia Schippel; Hans-Peter Volz
Journal:  Bipolar Disord       Date:  2009-08       Impact factor: 6.744

8.  Brain metabolic alterations in medication-free patients with bipolar disorder.

Authors:  Stephen R Dager; Seth D Friedman; Aimee Parow; Christina Demopulos; Andrew L Stoll; In Kyoon Lyoo; David L Dunner; Perry F Renshaw
Journal:  Arch Gen Psychiatry       Date:  2004-05

9.  Weight changes associated with antiepileptic mood stabilizers in the treatment of bipolar disorder.

Authors:  Koen P Grootens; Anna Meijer; Erwin G Hartong; Bennard Doornbos; P Roberto Bakker; Asmar Al Hadithy; Kirsten N Hoogerheide; Frans Overmeire; Radboud M Marijnissen; Henricus G Ruhe
Journal:  Eur J Clin Pharmacol       Date:  2018-08-07       Impact factor: 2.953

Review 10.  Disturbance of the glutamatergic system in mood disorders.

Authors:  Chansoo Jun; Yera Choi; Soo Mee Lim; Sujin Bae; Young Sun Hong; Jieun E Kim; In Kyoon Lyoo
Journal:  Exp Neurobiol       Date:  2014-03-27       Impact factor: 3.261

View more
  1 in total

Review 1.  The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder.

Authors:  Maria Carolina Bittencourt Gonçalves; Roberta Andrejew; Carolina Gubert
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.